Home/Filings/4/0001628280-25-056627
4//SEC Filing

Stokes Frank 4

Accession 0001628280-25-056627

CIK 0001447362other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 6:46 PM ET

Size

13.2 KB

Accession

0001628280-25-056627

Insider Transaction Report

Form 4
Period: 2025-12-09
Stokes Frank
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-09+14,61657,944 total
  • Tax Payment

    Common Stock

    2025-12-09$38.25/sh6,534$249,92651,410 total
  • Exercise/Conversion

    Common Stock

    2025-12-10+6,17057,580 total
  • Tax Payment

    Common Stock

    2025-12-10$38.02/sh2,758$104,85954,822 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-12-0914,61614,617 total
    Common Stock (14,616 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-12-106,1700 total
    Common Stock (6,170 underlying)
Footnotes (3)
  • [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
  • [F2]On December 9, 2022, the Reporting Person was granted 58,467 RSUs which vest in four equal installments beginning on December 9, 2023.
  • [F3]On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022.

Issuer

CASTLE BIOSCIENCES INC

CIK 0001447362

Entity typeother

Related Parties

1
  • filerCIK 0001782815

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 6:46 PM ET
Size
13.2 KB